Blue Jays go upside in late round two, drafting Bo Bichette

Oct 19, 2015; Toronto, Ontario, CAN; Fans line up to enter Rogers Centre prior to game three of the ALCS between the Toronto Blue Jays and the Kansas City Royals. Mandatory Credit: Dan Hamilton-USA TODAY Sports
Oct 19, 2015; Toronto, Ontario, CAN; Fans line up to enter Rogers Centre prior to game three of the ALCS between the Toronto Blue Jays and the Kansas City Royals. Mandatory Credit: Dan Hamilton-USA TODAY Sports

The Toronto Blue Jays have selected SS Bo Bichette in the second round, 66th overall, of the 2016 MLB Draft

High school shortstop Bo Bichette has been selected by the Toronto Blue Jays with the 66th overall pick in the 2016 MLB Draft.

The 18-year-old son of former major-league Dante Bichette was considered by some to be on the edge of a first-round talent entering the draft. He is currently committed to play his college ball at Arizona State University.

Chris Cotillo of MLB Daily Dish recently asked Bichette which major league players he models his game after.

More from Toronto Blue Jays News

“I would say, as a hitter, probably Josh Donaldson. He’s really aggressive, swings as hard as he can. That’s one of my goals every time I’m hitting, to let it loose. As a defender, someone like Troy Tulowitzki. He plays through-balls all the time, I do that quite a bit. I’d say those two guys.”

Not a bad place to land.

Bichette comes with serious power potential and while he may not stick at shortstop, scouts expect him to stick in the infield. Earlier this week, he was named Florida’s “Mr. Baseball.”

Blue Jays fans will find some familiarity in the swing of Bichette, as he features a prominent leg kick. There are a great deal of moving parts in his swing, however, that he will need to overcome or alter as he matures.

Earlier in the evening, the Blue Jays made University of Pittsburgh right-hander T.J. Zeuch (pronounced ‘Zoik’) their first-round pick at number 21. Ole Miss outfielder J.B. Woodman was then selected in the second round, 56th overall.